Dogwood Therapeutics, Inc.
DWTXAs of the close on Sep 25, 2026
Price
$1.36
Market cap
$46.2M
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Dogwood Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Activest Wealth Management | 2026-03-31 | 120 | Not shown | SEC filing |
| ARMISTICE CAPITAL, LLC | 2026-03-31 | 3,280,000 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 7,085 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 30 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 2 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 23,779 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 8,067 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 14,598 | Not shown | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 9 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 79,434 | Not shown | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 11,756 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2025-12-31 | 9,415 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-12-31 | 477 | Not shown | SEC filing |
| GROUP ONE TRADING LLC | 2025-12-31 | 9 | Not shown | SEC filing |
| BlackRock, Inc. | 2025-12-31 | 30 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2025-12-31 | 16,779 | Not shown | SEC filing |
| Activest Wealth Management | 2025-12-31 | 120 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2025-12-31 | 2 | Not shown | SEC filing |
| VANGUARD GROUP INC | 2025-12-31 | 29,955 | Not shown | SEC filing |
| UBS Group AG | 2025-12-31 | 1,748 | Not shown | SEC filing |
- Each value is checked against Dogwood Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- MARSHALL WACE, LLP: 11,655 shares reported 2025-12-31; 11,756 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 16,779 shares reported 2025-12-31; 79,434 shares reported 2026-03-31.
- GROUP ONE TRADING LLC: 9 shares reported 2025-12-31; 9 shares reported 2026-03-31.
- Tower Research Capital LLC (TRC): 744 shares reported 2025-09-30; 8,067 shares reported 2026-03-31.
- BNP PARIBAS FINANCIAL MARKETS: 2 shares reported 2025-12-31; 2 shares reported 2026-03-31.
- BlackRock, Inc.: 30 shares reported 2025-12-31; 30 shares reported 2026-03-31.
- UBS Group AG: 1,748 shares reported 2025-12-31; 7,085 shares reported 2026-03-31.
- Activest Wealth Management: 120 shares reported 2025-12-31; 120 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 15,084 shares reported 2025-09-30; 16,779 shares reported 2025-12-31.
- GROUP ONE TRADING LLC: 9 shares reported 2025-09-30; 9 shares reported 2025-12-31.
- BNP PARIBAS FINANCIAL MARKETS: 10 shares reported 2025-09-30; 2 shares reported 2025-12-31.
- BlackRock, Inc.: 30 shares reported 2025-09-30; 30 shares reported 2025-12-31.
Showing the 12 most recent filer reports.
30 filers have only one report here.
Independent insiders buying near the same time
- 2023-08-17–2023-08-21: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-05-17–2022-05-23: 5 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2022-01-03–2022-01-07: 5 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2021-12-21–2021-12-23: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2021-01-28–2021-01-29: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-08-21 | Pridgen William · Director | Common Stock | P — Open market or private purchase | +15,335 | 1.30 | SEC filing |
| 2023-08-17 | Duncan Gregory Scott · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +25,000 | 1.25 | SEC filing |
| 2022-12-08 | Whitley Richard James · Director | Common Stock | S — Open market or private sale | −1,800 | 0.26 | SEC filing |
| 2022-05-23 | Walsh Angela · SVP OF FINANCE | Common Stock | P — Open market or private purchase | +2,000 | 4.58 | SEC filing |
| 2022-05-23 | Duncan Gregory Scott · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +7,500 | 4.52 | SEC filing |
| 2022-05-18 | Pridgen William · Director | Common Stock | P — Open market or private purchase | +241 | 4.50 | SEC filing |
| 2022-05-18 | Whitley Richard James · Director | Common Stock | P — Open market or private purchase | +500 | 4.53 | SEC filing |
| 2022-05-17 | Pridgen William · Director | Common Stock | P — Open market or private purchase | +13,450 | 4.38 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-16 | Thomas John C · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,800 | SEC filing |
| 2026-06-16 | Whitley Richard James · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,800 | SEC filing |
| 2026-06-16 | Keefer David R · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,800 | SEC filing |
| 2026-06-16 | De La Rosa Abel · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,800 | SEC filing |
| 2026-03-05 | Duncan Gregory Scott · CHIEF EXECUTIVE OFFICER | Stock Option (right to buy) | A — Grant, award, or other acquisition | +330,000 | SEC filing |
| 2026-03-05 | Gendreau Roger Michael · CHIEF MEDICAL OFFICER | Stock Option (right to buy) | A — Grant, award, or other acquisition | +82,500 | SEC filing |
| 2026-03-05 | Grosswald Ralph · SVP OF OPERATIONS | Stock Option (right to buy) | A — Grant, award, or other acquisition | +82,500 | SEC filing |
| 2026-03-05 | Walsh Angela · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +82,500 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.